{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:51:25Z","timestamp":1791089485248,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/ypg.0b013e3280298292","type":"journal-article","created":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T03:51:49Z","timestamp":1173930709000},"page":"47-53","source":"Crossref","is-referenced-by-count":16,"title":["Association between CCK-AR gene and schizophrenia with auditory hallucinations"],"prefix":"10.1097","volume":"17","author":[{"given":"Ivette","family":"Toirac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Sanju\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo J.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"N\u00e1jera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"de Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210213","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg777","article-title":"Patterns of linkage disequilibrium in the human genome","volume":"3","author":"Ardlie","year":"2002","journal-title":"Nat Rev Genet"},{"key":"R2-1-20210213","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gkh438","article-title":"PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level","volume":"32","author":"Conde","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"R3-1-20210213","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(03)00767-5","article-title":"Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats","volume":"348","author":"Feifel","year":"2003","journal-title":"Neurosci Lett"},{"key":"R4-1-20210213","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0024-3205(83)90797-X","article-title":"Reduced cholecystokinin-like and somatostatinlike immunoreactivity in limbic lobe associated with negative symptoms in schizophrenia","volume":"33","author":"Ferrier","year":"1983","journal-title":"Life Sci"},{"key":"R5-1-20210213","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1399-0004.1999.560508.x","article-title":"Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's disease","volume":"56","author":"Fujii","year":"1999","journal-title":"Clin Genet"},{"key":"R6-1-20210213","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0014-5793(00)01080-2","article-title":"Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism","volume":"466","author":"Funakoshi","year":"2000","journal-title":"FEBS Lett"},{"key":"R7-1-20210213","first-page":"377","article-title":"Cholecystokinin, dopamine and schizophrenia","volume":"26","author":"Garver","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"R8-1-20210213","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archneur.61.8.1280","article-title":"Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system","volume":"61","author":"Goldman","year":"2004","journal-title":"Arch Neurol"},{"key":"R9-1-20210213","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1017\/S0033291799008661","article-title":"Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS)","volume":"29","author":"Haddock","year":"1999","journal-title":"Psychol Med"},{"key":"R10-1-20210213","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0006-8993(95)00518-U","article-title":"Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats","volume":"688","author":"Hamilton","year":"1995","journal-title":"Brain Res"},{"key":"R11-1-20210213","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.07-09-02967.1987","article-title":"Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists","volume":"7","author":"Hill","year":"1987","journal-title":"J Neurosci"},{"key":"R12-1-20210213","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1523\/JNEUROSCI.10-04-01070.1990","article-title":"Autoradiographical detection of cholecystokinin-a receptors in primate brain using 1251-Bolton Hunter CCK-8 and 3H-MK-329","volume":"10","author":"Hill","year":"1990","journal-title":"J Neurosci"},{"key":"R13-1-20210213","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/geno.1997.4749","article-title":"Human cholecystokinin Type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM)","volume":"42","author":"Inoue","year":"1997","journal-title":"Genomics"},{"key":"R14-1-20210213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajmg.b.10020","article-title":"Association between the CCK-A receptor gene and panic disorder","volume":"118","author":"Ise","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R15-1-20210213","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11920-005-0049-9","article-title":"Hallucinations in the general population","volume":"7","author":"Johns","year":"2005","journal-title":"Curr Psychiatry Rep"},{"key":"R16-1-20210213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R17-1-20210213","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/syn.890080207","article-title":"Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons","volume":"8","author":"Kelland","year":"1991","journal-title":"Synapse"},{"key":"R18-1-20210213","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1461145705005468","article-title":"Analysis of SNP profiles in patients with major depressive disorder","volume":"9","author":"K\u00f6ks","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"R19-1-20210213","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","article-title":"A standardized psychiatric assessment scale for rating chronic psychotic patients","volume":"55","author":"Krawiecka","year":"1977","journal-title":"Acta Psychiatr Scand"},{"key":"R20-1-20210213","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.b.20160","article-title":"Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese","volume":"127B","author":"Miyasaka","year":"2004","journal-title":"Am J Med Genet"},{"key":"R21-1-20210213","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0278-5846(85)90011-9","article-title":"Cholecystokinin peptides, dopamine and schizophrenia \u2013 a review","volume":"9","author":"Nair","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R22-1-20210213","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0031-6997(24)01427-3","article-title":"International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors","volume":"51","author":"Noble","year":"1999","journal-title":"Pharmacol Rev"},{"key":"R23-1-20210213","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15288\/jsa.2001.62.413","article-title":"Polymorphisms of the CCK, CCK-AR and CCK-BR genes: an association with alcoholism study","volume":"62","author":"Okubo","year":"2001","journal-title":"J Stud Alcohol"},{"issue":"(8 Suppl)","key":"R24-1-20210213","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/j.1530-0277.2002.tb02693.x","article-title":"Investigation of quantitative trait loci in the CCK-AR gene with susceptibility to alcoholism","volume":"26","author":"Okubo","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"R25-1-20210213","first-page":"480","article-title":"Electrophysiological effects of diphenylpyrazolidinone holecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons","volume":"264","author":"Rasmussen","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"R26-1-20210213","first-page":"171","article-title":"Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models","volume":"28","author":"Rotzinger","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"R27-1-20210213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eurpsy.2004.06.015","article-title":"A possible association between the CCK-AR gene and persistent hallucinations in schizophrenia","volume":"19","author":"Sanju\u00e1n","year":"2004","journal-title":"European Psychiatry"},{"key":"R28-1-20210213","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1461145705005559","article-title":"Serotonin transporter gene polymorphism (5-HTTLPR) and emotional response to auditory hallucinations in schizophrenia","volume":"9","author":"Sanju\u00e1n","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"R29-1-20210213","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1192\/bjp.188.2.190-a","article-title":"Time for a broad phenotype in schizophrenia?","volume":"188","author":"Sanju\u00e1n","year":"2006a","journal-title":"Br J Psychiatry"},{"key":"R30-1-20210213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.ypg.0000185029.35558.bb","article-title":"Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations","volume":"16","author":"Sanju\u00e1n","year":"2006b","journal-title":"Psychiatr Genet"},{"key":"R31-1-20210213","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archpsyc.57.11.1033","article-title":"Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging","volume":"57","author":"Shergill","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R32-1-20210213","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-1781(01)00276-1","article-title":"Linked polymorphisms (\u2212333G>T and \u2212286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia","volume":"103","author":"Tachikawa","year":"2001","journal-title":"Psychiatry Res"},{"key":"R33-1-20210213","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s005350200135","article-title":"Promoter analysis of human cholecystokinin type-A receptor gene","volume":"37","author":"Takata","year":"2002","journal-title":"J Gastroenterol"},{"key":"R34-1-20210213","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008571-200306000-00008","article-title":"Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease","volume":"13","author":"Wang","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R35-1-20210213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-9338(99)80719-6","article-title":"The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia","volume":"14","author":"Wei","year":"1999","journal-title":"Eur Psychiatry"},{"key":"R37-1-20210213","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.mp.4000677","article-title":"The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia","volume":"5","author":"Zhang","year":"2000","journal-title":"Mol Psychiatry"}],"container-title":["Psychiatric Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/YPG.0b013e3280298292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:33:45Z","timestamp":1786034025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041444-200704000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ypg.0b013e3280298292","relation":{},"ISSN":["0955-8829"],"issn-type":[{"value":"0955-8829","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}